ArticleJournal of shoulder and elbow arthroplasty2026
Effect of prior breast cancer treatment on outcomes of reverse total shoulder arthroplasty.
Article in Journal of shoulder and elbow arthroplasty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reverse total shoulder arthroplasty (rTSA) provides reliable outcomes in cuff tear arthropathy, but the impact of prior breast cancer treatment on safety and functional outcomes remains unclear. Methods: We conducted a retrospective cohort study of 15 women with prior ipsilateral breast cancer treatment (mastectomy, lymph node dissection, and/or radiotherapy) who underwent rTSA for cuff tear arthropathy. These results were compared with 50 female patients who underwent rTSA for cuff tear arthropathy without breast cancer history. Outcomes included patient-reported scores (Oxford Shoulder Score, Constant Murley score, and satisfaction), range of motion, pain, and complications, with a minimum follow-up of 2 years. Results: Oxford Shoulder Score and Constant Murley score were similar between groups (41.5 vs. 41.0; 69.4 vs. 71.8). Satisfaction was high in both cohorts (8.8/10). The breast cancer group showed lower abduction (139° vs. 166°, Conclusion: rTSA demonstrated comparable functional outcomes and satisfaction in patients with prior breast cancer treatment. Lower post-operative abduction, forward flexion and a numerically higher complication burden were observed, although complication differences were not statistically significant. Prior breast cancer treatment should not be considered an absolute contraindication, but appropriate pre-operative counseling remains important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.